ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Comm - Wikidata - awgldk - TriplyDB

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Comm

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Comm

http://www.wikidata.org/entity/Q34098946

about

Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control Atrial fibrillation and sleep-disordered breathing Rate-control or rhythm-control: where do we stand?Management of atrial fibrillation Simulation of Daily Snapshot Rhythm Monitoring to Identify Atrial Fibrillation in Continuously Monitored Patients with Stroke Risk Factors Atrial Fibrillation: The New Epidemic of the Ageing World Atrial electromechanical delay in patients undergoing heart transplantation.Sex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China.Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses Obstructive sleep apnea and cardiac arrhythmias.An exploration of the dynamic longitudinal relationship between mental health and alcohol consumption: a prospective cohort study.Fatal thyrocardiac event.N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.Antithrombotic therapy in cardiac embolism.A Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation.Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians The debate on warfarin use in dialysis patients with atrial fibrillation: more fuel for the fire.Permanent atrial fibrillation ablation surgery in patients with advanced age.Paroxysmal atrial fibrillation developed during incomplete epidural anesthesia -A case report-.Impact of rheumatoid arthritis disease activity test on clinical practice Atrial fibrillation: current concepts Freedom from atrial fibrillation after cox maze III ablation during follow-up.TheTGFB1 functional polymorphism rs1800469 and susceptibility to atrial fibrillation in two Chinese Han populations.Role of echocardiography in atrial fibrillation.Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry Inflammatory cytokines and atrial fibrillation: current and prospective views Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Role of oral anticoagulation in management of atrial fibrillation.Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital.The role of echocardiography in atrial fibrillation and cardioversion.Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortality The case for an elderly targeted stroke management.Stroke with atrial fibrillation or atrial flutter: a descriptive population-based study from the Brest stroke registry.Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.Catheter ablation of permanent atrial fibrillation: medium term results Antithrombotic treatment in atrial fibrillation.

P2860

Q24796053-9F49882E-93C7-45B6-96B7-34C4EC2F6796 Q24798420-2508FBA7-F6F6-4293-8D71-5D53FF6B43C0 Q24800344-8A28B8AE-C3F0-4AB5-84AB-F77943E7F582 Q26770269-5CB759FF-6D0B-4974-B005-95D10CB9ADF9 Q28200383-90FD2DBC-1437-4703-BF13-D6FA4ACE7220 Q28217428-20E5F2E8-F7DF-4FE6-B634-D3E855C6FFEE Q28550202-5F655970-7F9E-4EC2-A217-E7C6B1B26A00 Q33168630-FC850B21-29AF-4A4C-9ECB-85B4128ED6E5 Q33552987-473561FA-8A34-47F6-9FAA-02CEDE90BC99 Q33606961-C1268D91-0729-48A0-8550-D28FE47866CF Q33685872-4F390D51-BB8A-41DA-A297-B05CEF749AF2 Q33739756-C8BB5FDF-9675-4EE3-B9B5-04EA575B50D0 Q33740064-A10352D1-A510-4BE6-A1CC-8E0BF59604E8 Q34104651-52A21457-294E-4BAC-8B1D-EB71213930BE Q34171904-8134F19B-B1B1-48EF-AB1D-32516F617C9C Q34195562-52EB7121-2702-404E-98EB-C7CC0BFD69CD Q34362901-0020BB7F-E358-4927-9BB6-5A208ECA625F Q34398295-AA7A28CB-D725-42A9-AE9D-86F8BEE230E4 Q34398744-5FCC5872-2B65-48C5-92D3-70A08F5EEEA1 Q34403796-80389F65-F522-4E5A-9DCE-8E7707A950F7 Q34522114-F931F98D-93F1-44A7-A854-F6419B3B914E Q34535493-3684213D-E4E8-410D-A9ED-5B917F628715 Q34718059-B8572EF6-DA34-4D2E-A4FF-CF6ECC5FA847 Q34747164-05FD1169-27A0-4A1C-A7D7-B5F989D23632 Q35041666-6A35604F-71D6-4A46-A360-98019564F4D5 Q35070728-8942A3DD-B182-4491-82AA-676665983A59 Q35148789-53267E9C-2BAB-45BC-ADB1-2FE7F8D55912 Q35177830-E703BD95-0717-4F2A-AF5F-1233C543F81D Q35226363-C196D68F-728E-48F6-A308-93AE08D4B008 Q35557385-9EDED24B-4B09-421E-AE3A-376359F3586A Q35582163-89FFAB6E-B4A4-4184-8174-520C03C25628 Q35582611-3FE164CF-CCF6-4D36-819B-DD8098B96427 Q35583062-3B8E44DA-09E0-4F72-9C2E-959C59AE3C85 Q35583778-2C734FE1-1216-43E5-9F48-D59E8E3572F9 Q35587911-CB295602-460F-4635-A729-6FF138C0FF43 Q35641960-559C44B7-7853-446D-9B7C-6B2BFEA584DD Q35660429-B1D3D63B-B328-492A-9942-7A49BA66EEAA Q35737869-14BF7004-EAC2-4585-A5B8-61FEBF4C7703 Q35771196-09609B62-8D2B-49AB-8409-23060C35445F Q35771277-9A45D38F-E2D0-46BE-8579-DCBD36D7F560

P2860

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Comm

http://www.wikidata.org/entity/Q34098946

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@ast

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@en

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@nl

type

label

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@ast

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@en

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@nl

prefLabel

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@ast

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@en

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@nl

P1433

Q34098946-83FEA3AC-9245-49A3-BF1A-766AFA62BE1B

P1476

Q34098946-FD8330A9-7477-4AE1-B436-5DDCDEF9364B

P2093

Q34098946-021E07CF-4CDB-45E0-8D77-6AD3ACA93105

Q34098946-03CA5806-3FBE-4A60-817D-B14605A50C38

Q34098946-0CB3FDA8-231C-4DDE-9DDC-3F81E517D33E

Q34098946-1D176D1B-0623-47DF-9C8E-326ACC3BCA7E

Q34098946-2918B1C5-C53C-4536-B635-ECB0E754F006

Q34098946-2D9AE5C6-03CB-468F-BB9B-72F470FD7C17

Q34098946-326236DC-CE92-4151-8C87-402CE9396373

Q34098946-444312F9-1DDC-499D-899D-7ECC624710AF

Q34098946-4649E390-21EE-4244-A854-8672C6C4C0C6

Q34098946-495F328F-198F-4668-90F6-98DFAE2EDE1D

P304

Q34098946-9C7762C5-DD0D-48A8-882B-64960FF680F5

P31

Q34098946-77262E5D-CC18-4DEF-A8A3-558D8F233CF0

P407

Q34098946-75E7D76E-50D5-4C84-9DCA-A380D8708F3E

P433

Q34098946-4BB48B04-06B1-4A60-9569-2C546D510317

P478

Q34098946-578C1554-1056-4F68-99DC-C5FC313AFE46

P577

Q34098946-7A2B4931-C58A-4447-905D-6680154B373E

P698

Q34098946-7441128D-4AC4-470F-B1BE-1940C4DDE5C5

P921

Q34098946-A9B8FFF5-FEB5-4C3C-A391-4CFCCBD6515A

Q34098946-E82F1687-657A-4B9C-A706-58E7C1116FB1

P1433

P1476

ACC/AHA/ESC Guidelines for the ...... ean Society of Cardiology Comm

@en

P2093

A Alonso-Garcia

http://www.w3.org/2001/XMLSchema#string

A K Jacobs

http://www.w3.org/2001/XMLSchema#string

A Oto

http://www.w3.org/2001/XMLSchema#string

A Parkhomenko

http://www.w3.org/2001/XMLSchema#string

A Torbicki

http://www.w3.org/2001/XMLSchema#string

American College of Cardiology ...... k Force on Practice Guidelines

http://www.w3.org/2001/XMLSchema#string

C Blomström-Lundqvist

http://www.w3.org/2001/XMLSchema#string

D G Wyse

http://www.w3.org/2001/XMLSchema#string

D P Faxon

http://www.w3.org/2001/XMLSchema#string

D S Cannom

http://www.w3.org/2001/XMLSchema#string

P304

2118-2150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11673357

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation